The Medical Advisor

A team of U.S. clinicians will participate in an observational study to determine improvements in the five-year survival rate for several types of cancer WASHINGTON, D.C. – The Independent Medical Alliance (previously FLCCC Alliance) announced that it has partnered with renowned breast cancer physician and researcher Kathleen Ruddy, MD, to conduct an observational study in five U.S. clinics to track patient responses to various adjunct cancer therapies using repurposed drugs and determine improvements in the five-year survival rate to several types of cancer including breast, prostate, lung, and colorectal.   More people than ever will be diagnosed with cancer this year, according to the American Cancer Society. Conventional cancer treatments have succeeded in preventing more than 4 million deaths from cancer since 1991. However, emerging research continues to demonstrate that more can be done using treatment regimens that include well-studied repurposed drugs. “We hope that our r...

Background:   The overall mortality in sepsis has decreased quite a bit in the last decade or so, however for a subset of patients, like those with Septic Shock, the mortality still remains high (as high as 50%).  There have been hundreds of studies trying to identify the holy grail to decrease mortality further, but one has not been found thus far.  Marik PE et al [1] published a study in Chest 2016 that has found a potential front runner.  In addition, the authors go on to say, in order to have an impact on a global scale, treatments would not only need to be effective, but also cheap, safe, and readily available; the authors of the following paper may have found just that.. Update (2023):  World-Renowned Physician’s Landmark Research Validated by Medical Journal Following a Nearly Year-Long Investigation What They Did: Electronic Heath Record (EHR) retrospective before-after clinical study Compared the clinical course and outcome of consecutive severe sepsis ...

For nearly six months, Pierre and I have been seeing patients for adjunctive cancer care. In one week, as of 8/12/24, our adjunctive cancer care will be augmented Dr Sid Lawler, an internist with more than twenty years of clinical practice.  The Leading Edge Clinic  is one of five practices nationally participating in a five-year observational study sponsored by the FLCCC Alliance, evaluating the clinical benefit of a ketogenic (keto) diet, repurposed supplements and prescription medications in treating cancer. This intervention, an integration of a keto diet with layered therapy, is based upon the groundbreaking research of Dr Paul Marik and his  protocol  . Pierre is putting the finishing touches on a detailed four-part Substack series on this topic. In the meantime, I’m going to supply a focused update on what I’ve learned so far from our current patients. DIET AND GLUCOSE MONITORING CHALLENGES About fifty percent of my patients have had some kind of difficulty wi...

FLCCC (Front Line COVID-19 Critical Care) I-MASK+ Protocol I-MASK+ Prevention & Early Outpatient Treatment Protocol for COVID-19 was designed for use as a prevention and in early outpatient treatment, for those who test positive for COVID-19. Component nutrients include vitamin D, C, melatonin, quercetin and zinc . All the component medicines are FDA-approved (except ivermectin), inexpensive, readily available and have been used for decades with well-established safety profiles. Please take note that I-MASK+ protocols are now: I-PREVENT protocol for prevention (prophylaxis) I-CARE protocol for early treatment . PREVENTION PROTOCOL As rates of infection with influenza and RSV rose in fall/winter 2022, FLCCC adapted th...